These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 6229864)

  • 1. Intranasal ipratropium in the treatment of vasomotor rhinitis.
    Jokinen K; Sipilä P
    Rhinology; 1983 Dec; 21(4):341-5. PubMed ID: 6229864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A trial of intranasal Atrovent versus placebo in the treatment of vasomotor rhinitis.
    Knight A; Kazim F; Salvatori VA
    Ann Allergy; 1986 Nov; 57(5):348-54. PubMed ID: 2946252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of non-allergic nasal hypersecretion with ipratropium and beclomethasone.
    Jessen M; Bylander A
    Rhinology; 1990 Jun; 28(2):77-81. PubMed ID: 2143592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of locally applied ipratropium aerosol on the nasal methacholine challenge in patients with allergic and non-allergic rhinitis.
    Sanwikarja S; Schmitz PI; Dieges PH
    Ann Allergy; 1986 Feb; 56(2):162-6. PubMed ID: 2936282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal ipratropium: literature abstracts and comments.
    Mygind N; Borum P
    Rhinol Suppl; 1989; 9():37-44. PubMed ID: 2534054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ipratropium (Atrovent) in the treatment of vasomotor rhinitis of elderly patients.
    Malmberg H; Grahne B; Holopainen E; Binder E
    Clin Otolaryngol Allied Sci; 1983 Aug; 8(4):273-6. PubMed ID: 6228347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal ipratropium: inhibition of methacholine induced hypersecretion.
    Borum P
    Rhinology; 1978 Dec; 16(4):225-33. PubMed ID: 154164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of intranasal Atrovent in the treatment of vasomotor rhinitis.
    Hosen H
    Ann Allergy; 1987 Nov; 59(5):384. PubMed ID: 2961291
    [No Abstract]   [Full Text] [Related]  

  • 9. Vasomotor rhinitis and the systemic absorption of ipratropium bromide.
    Kaila T; Suonpää J; Grénman R; Iisalo E
    Rhinology; 1990 Jun; 28(2):83-9. PubMed ID: 2143593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind study of intranasal ipratropium bromide in nonallergic perennial rhinitis.
    Druce HM; Spector SL; Fireman P; Kaiser H; Meltzer EO; Boggs P; Wood CC; Paluch EP
    Ann Allergy; 1992 Jul; 69(1):53-60. PubMed ID: 1385682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of the hypersecretion of vasomotor rhinitis by topical ipratropium bromide.
    Dolovich J; Kennedy L; Vickerson F; Kazim F
    J Allergy Clin Immunol; 1987 Sep; 80(3 Pt 1):274-8. PubMed ID: 2957416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasal ipratropium bromide for paroxysmal rhinorrhoea.
    Bok HE; Van Wijngaarden HA; Cornelissen PJ
    Eur J Respir Dis Suppl; 1983; 128 (Pt 2)():486-9. PubMed ID: 6225668
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of ipratropium bromide on nasal hypersecretion induced by methacholine in patients with vasomotor rhinitis. A double-blind, cross-over, placebo-controlled and randomized dose-response study.
    Sjögren I; Jonsson L; Köling A; Jansson C; Osterman K; Håkansson B
    Acta Otolaryngol; 1988; 106(5-6):453-9. PubMed ID: 2974675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of the effects of intranasal botulinum toxin type A and ipratropium bromide nasal spray on nasal hypersecretion in idiopathic rhinitis without eosinophilia.
    Sapci T; Yazici S; Evcimik MF; Bozkurt Z; Karavus A; Ugurlu B; Ozkurt E
    Rhinology; 2008 Mar; 46(1):45-51. PubMed ID: 18444492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ipratropium nasal spray: a new treatment for rhinorrhea in the common cold.
    Borum P; Olsen L; Winther B; Mygind N
    Am Rev Respir Dis; 1981 Apr; 123(4 Pt 1):418-20. PubMed ID: 6452842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nasal hypersecretion treated with ipratropium].
    Borum P
    Lakartidningen; 1980 May; 77(21):2038-9. PubMed ID: 6447235
    [No Abstract]   [Full Text] [Related]  

  • 17. Intranasal ipratropium: a new treatment for perennial rhinitis.
    Borum P; Mygind N; Schultz Larsen F
    Clin Otolaryngol Allied Sci; 1979 Dec; 4(6):407-11. PubMed ID: 160846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common cold and high-dose ipratropium bromide: use of anticholinergic medication as an indicator of reflex-mediated hypersecretion.
    Ostberg B; Winther B; Borum P; Mygind N
    Rhinology; 1997 Jun; 35(2):58-62. PubMed ID: 9299652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nasal disorders and anticholinergic therapy.
    Borum P
    Postgrad Med J; 1987; 63 Suppl 1():61-8. PubMed ID: 2962076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ipratropium bromide nasal spray in non-allergic rhinitis: efficacy, nasal cytological response and patient evaluation on quality of life.
    Georgitis JW; Banov C; Boggs PB; Dockhorn R; Grossman J; Tinkelman D; Roszko P; Wood C
    Clin Exp Allergy; 1994 Nov; 24(11):1049-55. PubMed ID: 7874603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.